Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Randomized Placebo-controlled Trial of Nocturnal Oxygen Therapy in Chronic Obstructive Pulmonary Disease. The International Nocturnal Oxygen (INOX) Trial

NCT01044628 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT01044628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01044628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Randomized Placebo-controlled Trial of Nocturnal Oxygen Therapy in Chronic Obstructive Pulmonary Disease. The International Nocturnal Oxygen (INOX) Trial
Lead sponsor
Laval University
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2010
Completion date
January 31, 2019
Enrollment
243 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, nocturnal desaturation